Product Brief
PT-141 (Bremelanotide) works centrally through melanocortin pathways to enhance libido and sexual function — a unique mechanism distinct from PDE5 inhibitors.
Unlike peripheral-acting agents, PT-141 (Bremelanotide) works centrally through MC4R receptors in the hypothalamus to enhance sexual desire and arousal through a distinct melanocortin pathway.
Every Radiptide batch is manufactured under strict quality control and tested for identity and purity. Certificate of Analysis (COA) available on request.